3M (MMM) Aktievy
3M Company tillhandahåller diversifierade tekniktjänster i Amerika, Asien och Stillahavsområdet, Europa, Mellanöstern, Afrika och internationellt. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 3/6 |
| Framtida tillväxt | 2/6 |
| Tidigare resultat | 1/6 |
| Finansiell hälsa | 3/6 |
| Utdelningar | 3/6 |
MMM Community Fair Values
Create NarrativeSee what 321 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
3M Company Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | US$178.96 |
| 52 veckors högsta | US$184.90 |
| 52 veckors lägsta | US$139.34 |
| Beta | 1.08 |
| 1 månads förändring | 3.67% |
| 3 månaders förändring | 17.40% |
| 1 års förändring | 12.75% |
| 3 års förändring | 80.86% |
| 5 års förändring | -8.25% |
| Förändring sedan börsintroduktionen | 2,954.25% |
Senaste nyheter och uppdateringar
Uppdatering av berättelse • Aug 17
MMM: New Product Flywheel And Q2 Execution Will Support Future Re Rating
The analyst fair value estimate for 3M has been raised from $209 to $219 as analysts factor in stronger revenue growth assumptions, slightly higher profit margins, and updated P/E expectations following a series of post earnings price target increases across the Street. Analyst Commentary Recent research updates show a clear shift toward a more constructive view on 3M, with a cluster of higher price targets and some rating upgrades following the latest Q2 report.
Uppdatering av berättelse • Aug 03
MMM: Q2 Execution And AI Ties Will Test PFAS Legal Overhang
The analyst price target for 3M has shifted higher in recent weeks, with the updated fair value estimate moving from about $171 to roughly $182, as analysts cite stronger Q2 earnings, improved organic growth and productivity, and a more confident multi year outlook for the company's product pipeline. Analyst Commentary Recent research on 3M shows a wide range of views on the stock, even as many analysts lift their price targets following the Q2 report and updated guidance.Recent updates
Uppdatering av berättelse • Aug 17
MMM: New Product Flywheel And Q2 Execution Will Support Future Re Rating
The analyst fair value estimate for 3M has been raised from $209 to $219 as analysts factor in stronger revenue growth assumptions, slightly higher profit margins, and updated P/E expectations following a series of post earnings price target increases across the Street. Analyst Commentary Recent research updates show a clear shift toward a more constructive view on 3M, with a cluster of higher price targets and some rating upgrades following the latest Q2 report.Uppdatering av berättelse • Aug 03
MMM: Q2 Execution And AI Ties Will Test PFAS Legal Overhang
The analyst price target for 3M has shifted higher in recent weeks, with the updated fair value estimate moving from about $171 to roughly $182, as analysts cite stronger Q2 earnings, improved organic growth and productivity, and a more confident multi year outlook for the company's product pipeline. Analyst Commentary Recent research on 3M shows a wide range of views on the stock, even as many analysts lift their price targets following the Q2 report and updated guidance.Seeking Alpha • Jul 21
3M: The Turnaround Is Real, But Already Priced In
Summary 3M Company remains a Hold as valuation reached its fair value, even when taking into account the strong Q2 performance and guidance boost. 3M delivered 5.4% sales growth, 12% EPS growth in H1, and raised 2026 EPS guidance to $8.80–$8.95. Litigation liabilities and macro/geopolitical risks continue to weigh on 3M's risk-reward profile. AI/data center exposure and portfolio optimization offer long-term growth, but current risk-reward is unattractive. Read the full article on Seeking Alpha
Uppdatering av berättelse • Jul 20
MMM: PFAS Lawsuits Will Continue To Cap Upside Despite Improving Demand
Analysts have adjusted their fair value estimate for 3M slightly lower to about $121.62. This reflects a modestly higher discount rate alongside marginally stronger assumptions for revenue growth, profit margins, and a lower future P/E, informed by recent price target changes that highlight both optimism around improving industrial demand and ongoing concerns about execution and legacy risks.Uppdatering av berättelse • Jul 06
MMM: Transformation And Legal Progress Will Support Future Re Rating
Analysts have trimmed their fair value estimate for 3M from $222.65 to $209.00. This reflects updated assumptions around discount rates, profit margins, and longer running concerns such as persistent PFAS liabilities and questions about the pace of the company's innovation recovery.Uppdatering av berättelse • Jun 22
MMM: Future Margin Execution Faces PFAS Legal Risks After Solventum Spin
Analysts have trimmed their price expectations for 3M, with the updated fair value estimate moving from about $175.03 to $170.97, as recent research has highlighted concerns around execution risks in reigniting growth and ongoing PFAS liabilities, even as margin assumptions improved slightly. Analyst Commentary Recent Street research on 3M points to a mixed setup, with analysts split between concerns around execution and liabilities and some recognition that management has pulled meaningful levers through the ongoing transformation and portfolio moves such as the Solventum spin.Uppdatering av berättelse • Jun 06
MMM: PFAS Lawsuit And Overhang Will Constrain Future Upside Potential
Analysts have adjusted their view on 3M, with the implied fair value price target moving from about $125.70 to around $127.90. This reflects updated assumptions on revenue growth, profit margins, and future P/E following the Solventum spin and mixed recent price target changes across the Street.Uppdatering av berättelse • May 23
MMM: Margin Execution And Cash Returns Will Support Future Re Rating
Analysts have trimmed their 3M price target by about $1, reflecting slightly lower fair value estimates even as updated models factor in a reduced discount rate, modestly higher revenue growth, a small uptick in projected profit margins, and a somewhat lower future P/E assumption. Analyst Commentary Recent Street research around 3M and its healthcare spin-off Solventum gives you a mixed but generally constructive picture, with attention on how the separation could reshape both companies' earnings profiles and valuation frameworks.Uppdatering av berättelse • May 03
MMM: Future Margin Execution And Buybacks Will Support Turnaround Prospects
Analysts have adjusted the 3M price target slightly lower to reflect a new fair value near $175, as recent target cuts from several firms and one smaller increase from Wells Fargo suggest a more cautious view on profit margins, while revenue growth assumptions and future P/E expectations remain steady to slightly higher. Analyst Commentary Recent Street research reflects a more mixed stance on 3M, with several firms trimming price targets and one lifting its target, all clustering around a fair value in the mid US$170s.Uppdatering av berättelse • Apr 18
MMM: Execution On Margin Efficiency And Buybacks Will Support Future Re Rating
Analysts have trimmed their 3M fair value estimate by about $2 to $223.59, reflecting slightly lower profit margin assumptions that are only partly balanced by a modestly higher revenue growth outlook and a marginally richer future P/E multiple. Analyst Commentary Recent Street research on 3M reflects a mix of cautious revisions and selective optimism, with several firms adjusting price targets both higher and lower in response to updated assumptions.Uppdatering av berättelse • Apr 04
MMM: Operational Discipline And Legal Resolution Will Support Future Re Rating
Analysts have reduced the updated price target on 3M by about $1 to $225.94. This reflects a combination of recent target cuts and increases across firms, along with slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E.Uppdatering av berättelse • Mar 21
MMM: Operational Progress And Legal Overhang Resolution Will Support Future Re Rating
The analyst price target for 3M has been adjusted by a few dollars, reflecting mixed but generally constructive updates from recent research. Some firms raised their targets by $2 to $5, while others trimmed theirs by $6 to $8, based on refreshed views of growth, profitability, and valuation assumptions.Uppdatering av berättelse • Mar 06
MMM: Digital And Legal Progress Will Support Future Re Rating
The analyst price target for 3M has edged higher by about $1.50, as analysts weighed mixed target moves from major firms alongside slightly updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent Street research on 3M has been mixed, with some firms trimming their price targets while others raised theirs.Uppdatering av berättelse • Feb 20
MMM: Digital Execution And Slightly Higher Fair Value Will Support Re Rating
The analyst price target for 3M has shifted slightly higher, with our fair value estimate moving from $223.00 to about $225.67 as analysts factor in updated growth and margin assumptions, along with mixed target revisions across major firms. Analyst Commentary Recent Street research on 3M shows a split view, with several bullish analysts lifting price targets and others trimming expectations or downgrading the stock.Uppdatering av berättelse • Feb 05
MMM: Turnaround Prospects Will Be Tested By PFAS Litigation And Mixed Street Expectations
The analyst price target on 3M has been revised slightly higher to about $177 from $174, as analysts adjust their models for small changes in fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following a mix of recent target increases and cuts across major firms. Analyst Commentary Recent Street research on 3M has been mixed, with several firms adjusting their price targets in both directions and one major downgrade.Uppdatering av berättelse • Jan 22
MMM: New Digital Tools And Higher P E Multiple Will Support Re Rating
Analysts have nudged their valuation view on 3M higher, with the updated fair value estimate moving from $212 to $223 as they reassess the stock's longer term earnings power and apply a slightly richer future P/E multiple, despite mixed recent price target changes across the Street. Analyst Commentary Recent Street research on 3M has been mixed, with some firms trimming targets or ratings and others lifting their valuation marks.Uppdatering av berättelse • Jan 07
MMM: Reset Expectations And New Products Will Support Higher Margins
Analysts have raised their fair value estimate for 3M to $212 from $187, citing expectations for higher profit margins, a slightly lower discount rate, and supportive Street research that highlights Q3 execution, new product traction, and reset expectations across multiple firms. Analyst Commentary Recent Street research around 3M clusters around a more constructive setup following Q3, with several bullish analysts revisiting their models on the back of reset expectations, new product traction, and updated legal and macro assumptions.Uppdatering av berättelse • Dec 24
MMM: PFAS Litigation Will Ultimately Cap Upside Despite Turnaround Progress
Analysts have raised their price target on 3M, lifting fair value by about $12 per share to roughly $126 as they grow more confident in the company’s improving organic growth, margin expansion, and turnaround initiatives, despite ongoing PFAS litigation risks. Analyst Commentary Recent Street research reflects a more balanced, but still risk aware, view on 3M as estimates reset and execution on the turnaround improves.Uppdatering av berättelse • Dec 10
MMM: Turnaround Progress Will Face Ongoing PFAS Litigation And Portfolio Reshaping Risks
Our fair value estimate for 3M has been trimmed slightly to $174.25 from $174.94 as analysts balance higher price targets and improving expectations for new product driven growth and management's turnaround progress against persistent PFAS litigation risk. Analyst Commentary Street research remains divided on 3M, with recent notes highlighting improving execution and product driven growth, offset by continued concern around PFAS liabilities and mixed end market demand.Uppdatering av berättelse • Nov 26
MMM: Shares Will Balance Turnaround Progress With Litigation and Asset Sale Uncertainty
Analysts have marginally raised their fair value estimate for 3M to $174.94, citing improved organic growth, ongoing new product introductions, and increased profit margin expectations following recent quarterly results. Analyst Commentary Recent analyst research has revealed a shifting perspective on 3M, as several experts adjust their outlooks based on the company’s latest earnings performance and ongoing strategic initiatives.Uppdatering av berättelse • Nov 06
MMM: Shares Will Balance Turnaround Progress With Ongoing Litigation and Portfolio Changes
Analysts have raised their fair value estimate for 3M to $174.31 from $167.81. This change reflects improved organic growth prospects and progress on turnaround initiatives highlighted in recent research updates.Uppdatering av berättelse • Oct 22
Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks
3M's fair value estimate has increased by $5.00 to $167.81 as analysts cite modest operating outperformance and positive momentum from new product initiatives, despite some lingering concerns. Analyst Commentary Recent updates from Street research highlight diverging analyst sentiment regarding 3M's valuation trajectory and execution on strategic initiatives.Uppdatering av berättelse • Oct 08
New Product Launches And Efficiency Gains Will Boost Future Value
Narrative Update: 3M Analyst Price Target Revision Analysts have increased their price target for 3M to $162.81 from $161.63, citing improved full-year guidance prospects and renewed interest as a short-term buy idea. Analyst Commentary Recent commentary from Street research highlights both optimistic and cautious stances regarding 3M’s near-term prospects.Seeking Alpha • Mar 11
3M: Multiple Expansion Amidst Turnaround Success
Summary 3M has shown signs of a turnaround with a doubling stock price since October 2023, but operational top line growth remains modest, justifying a "hold" rating. The company expects modest organic revenue growth of 2-3% in 2025, driven by innovations and new product launches, but analysts are less optimistic. Current valuation is high with a forward P/E ratio above the five-year median, limiting upside potential amid risks like trade disputes and economic slowdowns. Read the full article on Seeking AlphaSeeking Alpha • Feb 07
3M: More Upside Ahead - But Wait For A Moderate Retracement
Summary MMM's reversal is already here, thanks to the SOLV divestiture bringing forth a more focused portfolio and healthier balance sheet. This is on top of the resolution of its legal headwinds, as management also pursues insurance recovery and $340M already completed. The management has driven new growth opportunities through its legacy businesses and new product launches as well, despite certain market softness. These reasons are likely why the market has upgraded MMM's valuations and the investors have defended the stock's uptrend support line thus far. With double digit capital appreciation prospects, we are reiterating our Buy rating here with one caveat. We shall further discuss. Read the full article on Seeking AlphaSeeking Alpha • Jan 23
3M Is Structurally Shifting For Durable Growth
Summary 3M's focus on innovation and operational improvements under CEO Bill Brown may lead to significant top-line growth and margin expansion. Management is aiming to enhance supply chain efficiencies and increasing production launches while improving the firm's on-time, in-full deliveries. 3M has a substantial amount of inventory that may be worked down in the coming quarters, potentially acting as a tailwind for free cash flow generation in the coming years. Read the full article on Seeking AlphaSeeking Alpha • Jan 06
Downgrading 3M Due To Persistent Litigation Risks And Stagnant Sales Growth
Summary I am downgrading 3M from hold to sell due to slow revenue growth, ongoing litigation risks, and inflated stock valuation despite recent gains. Revenue growth is expected to underpace inflation, driven by product line adjustments, declining European demand, and the healthcare spin-off. Despite settling some litigations, 3M faces significant pending lawsuits, posing substantial financial risks. Shares appear expensive when accounting for slow growth and litigation risks, with a fair value estimate of $86 per share, 34% below current trading. Read the full article on Seeking AlphaAktieägarnas avkastning
| MMM | US Industrials | US Marknad | |
|---|---|---|---|
| 7D | -2.0% | -4.5% | -1.2% |
| 1Y | 12.8% | -29.3% | 18.3% |
Avkastning vs industri: MMM översteg US Industrials branschen som gav -29.3 % under det senaste året.
Avkastning vs Marknaden: MMM presterade sämre än US marknaden som gav 18.3 % under det senaste året.
Prisvolatilitet
| MMM volatility | |
|---|---|
| MMM Average Weekly Movement | 3.5% |
| Industrials Industry Average Movement | 8.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stabil aktiekurs: MMM har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.
Volatilitet över tid: MMM s veckovolatilitet ( 3% ) har varit stabil under det senaste året.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 1902 | 60,500 | Bill Brown | www.3m.com |
3M Company tillhandahåller diversifierade tekniktjänster i Amerika, Asien och Stillahavsområdet, Europa, Mellanöstern, Afrika och internationellt. Verksamheten bedrivs genom tre segment: Safety and Industrial, Transportation and Electronics samt Consumer. Segmentet Safety and Industrial erbjuder industriella slipmedel och ytbehandling för metallbearbetning, lösningar för bilreparationer, specialprodukter för industrin, t.ex. produkter för personlig hygien, maskerings- och förpackningsmaterial, elektriska produkter och material för konstruktion och underhåll, kraftdistribution och tillverkare av elektrisk originalutrustning, strukturella lim och tejp, lösningar för andnings-, hörsel-, ögon- och fallskydd samt naturliga och färgbelagda mineralgranulat för shingel.
3M Company Sammanfattning av grunderna
| MMM grundläggande statistik | |
|---|---|
| Börsvärde | US$92.29b |
| Vinst(TTM) | US$3.00b |
| Intäkter(TTM) | US$25.18b |
30.8x
P/E-förhållande3.7x
P/S-förhållandeÄr MMM övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| MMM resultaträkning (TTM) | |
|---|---|
| Intäkter | US$25.18b |
| Kostnad för intäkter | US$15.26b |
| Bruttovinst | US$9.92b |
| Övriga kostnader | US$6.93b |
| Intäkter | US$3.00b |
Senast redovisade vinst
Jun 30, 2026
Nästa vinstdatum
n/a
| Vinst per aktie (EPS) | 5.81 |
| Bruttomarginal | 39.41% |
| Nettovinstmarginal | 11.90% |
| Skuld/egenkapitalförhållande | 417.7% |
Hur har MMM utvecklats på lång sikt?
Se historisk utveckling och jämförelseUtdelningar
1.7%
Aktuell utdelningsavkastning53%
UtbetalningskvotGer MMM en tillförlitlig utdelning?
Se MMM utdelningshistorik och jämförelsetal| 3M datum för utdelning | |
|---|---|
| Ex utdelningsdag | Aug 24 2026 |
| Utbetalningsdag för utdelning | Sep 11 2026 |
| Dagar till Ex-utdelning | 0 days |
| Dagar till utdelningsdag | 18 days |
Ger MMM en tillförlitlig utdelning?
Se MMM utdelningshistorik och jämförelsetalFöretagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/08/23 05:11 |
| Aktiekurs vid dagens slut | 2026/08/21 00:00 |
| Intäkter | 2026/06/30 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
3M Company bevakas av 30 analytiker. 14 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| John Eade | Argus Research Company |
| Robert Cornell | Barclays |
| Julian Mitchell | Barclays |